Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis: new therapeutic considerations.

J M Hanifin1

  • 1Department of Dermatology, Oregon Health Sciences University, Portland 97201.

Journal of the American Academy of Dermatology
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pioneers in Dermatology and Venereology: an interview with Jon Hanifin, M.D.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality-of-life measure for adult atopic dermatitis.

The British journal of dermatology·2018
Same author

Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis.

The British journal of dermatology·2017
Same author

What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.

The British journal of dermatology·2015
Same author

Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Same author

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).

The British journal of dermatology·2014

Atopic dermatitis is a complex inflammatory skin disease with genetic roots, often triggered by stress and food. Treatments focus on barrier repair, symptom relief, and inhibiting inflammatory pathways for better skin health.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Atopic dermatitis is a genetically determined inflammatory skin condition.
  • It is a multifactorial disease triggered by various factors, including emotional stress and food.
  • Inflammatory cells like mast cells, eosinophils, monocytes, and T lymphocytes infiltrate the skin lesions.

Purpose of the Study:

  • To review the underlying mechanisms and therapeutic strategies for atopic dermatitis.
  • To highlight the role of genetic predisposition and external triggers in disease development.
  • To discuss current and emerging treatment approaches targeting inflammation and skin barrier function.

Main Methods:

  • Review of existing literature on atopic dermatitis.
  • Analysis of the pathophysiology involving immune cells and inflammatory mediators.

Related Experiment Videos

  • Examination of therapeutic targets and treatment modalities.

    • Main Results:

    • The primary defect in atopic dermatitis involves hematopoietic cells affecting the skin.
    • Inflammation is initiated by mast cells and involves other immune cells.
    • Secondary effects include a compromised stratum corneum and pruritus, leading to chronic changes.

    Conclusions:

    • Therapeutic strategies should address multiple aspects of atopic dermatitis, including skin barrier restoration and inflammation control.
    • Emollients and antipruritics are crucial for managing the condition.
    • Targeting inflammatory mediators, cytokine production, and infiltrating cells with novel agents offers promising treatment avenues.